Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice

被引:37
作者
Cohen, SL
Moore, AM
Ward, WE [1 ]
机构
[1] Univ Toronto, Fac Med, Dept Nutrit Sci, Toronto, ON M5S 3E2, Canada
[2] Hosp Sick Children, Dept Neonatol, Toronto, ON M5G 1X8, Canada
关键词
flaxseed oil; inflammatory bowel disease; bone mass; interleukin-10 knockout mice;
D O I
10.1016/j.jnutbio.2005.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-10(-/-) (IL-10) knockout (KO) mice develop an intestinal inflammation that closely mimics human inflammatory bowel disease (IBD) which is accompanied by inflammation-associated bone abnormalities and elevated serum proinflammatory cytokines. The objective of this study was to use the IL-10 KO mouse model to determine whether flaxseed oil (FO) diet, rich in alpha-linolenic acid (ALA), attenuates intestinal inflammation and inflammation-associated bone abnormalities, compared to a corn oil (CO) control diet. Male wild-type (WT) or IL-10 KO mice were fed a 10% CO or 10% FO diet from weaning (postnatal day 28) for 9 weeks. At necropsy, serum, intestine, femurs and lumbar vertebrae were collected and analyzed. IL-10 KO mice fed CO had lower femur bone mineral content (BMC; P <.001), bone mineral density (BMD; P <.001), peak load (P=.033) and lumbar vertebrae BMD (P=.02) compared to WT mice fed either diet. Flaxseed oil had a modest, favorable effect on IL-10 KO mice as femur BMC, BMD and peak load were similar to WT mice fed CO or FO. In addition, lumbar vertebra BMD was similar among IL-10 KO mice fed FO and WT mice fed CO or FO. The fact that FO attenuated serum tumor necrosis factor-alpha (TNF-alpha) among IL-10 KO mice suggests that the positive effects of FO on femur BMC, BMD, peak load and vertebral BMD in IL-10 KO mice may have been partly mediated by changes in serum TNF-alpha. In conclusion, these findings suggest that a dietary level of ALA attainable from a 10% flaxseed oil diet results in modest improvements in some bone outcomes but does not attenuate intestinal inflammation that is characteristic of IL-10 KO mice. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:368 / 374
页数:7
相关论文
共 50 条
[1]   METABOLIC BONE ASSESSMENT IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE [J].
ABITBOL, V ;
ROUX, C ;
CHAUSSADE, S ;
GUILLEMANT, S ;
KOLTA, S ;
DOUGADOS, M ;
COUTURIER, D ;
AMOR, B .
GASTROENTEROLOGY, 1995, 108 (02) :417-422
[2]  
American Gastroenterological Association, 2003, GASTROENTEROLOGY, V124, P791, DOI DOI 10.1053/GAST.2003
[3]  
ASLAN A, 1992, AM J GASTROENTEROL, V87, P432
[4]  
Belluzzi A, 2000, AM J CLIN NUTR, V71, p339S, DOI 10.1093/ajcn/71.1.339s
[5]   Bone density in a population-based cohort of premenopausal adult women with early onset inflammatory bowel disease [J].
Bernstein, CN ;
Leslie, WD ;
Taback, SP .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05) :1094-1100
[6]   Reduced bone density in patients with inflammatory bowel disease [J].
Bjarnason, I ;
Macpherson, A ;
Mackintosh, C ;
BuxtonThomas, M ;
Forgacs, I ;
Moniz, C .
GUT, 1997, 40 (02) :228-233
[7]   Insights from mouse models of colitis [J].
Boismenu, R ;
Chen, YP .
JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (03) :267-278
[8]   Bone mineral density and nutritional status in children with chronic inflammatory bowel disease [J].
Boot, AM ;
Bouquet, J ;
Krenning, EP ;
Keizer-Schrama, SMPFD .
GUT, 1998, 42 (02) :188-194
[9]   RDP58, a novel immunomodulatory peptide with anti- inflammatory effects.: A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease [J].
Bourreille, A ;
Doubremelle, M ;
Raingeard, D ;
de la Blétière, DR ;
Segain, JP ;
Toquet, C ;
Buelow, R ;
Galmiche, JP .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (05) :526-532
[10]  
*CAN COUNC AN CAR, 1984, GUID CAR UD EXP AN